Skip to content

EMLA Topical Anesthetic During Scaling and Root Planing

Topical Intrapocket Anesthesia With Prilocaine and Lidocaine as Alternative to Injectable Anesthesia During Scaling and Root Planing - A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01860235
Enrollment
32
Registered
2013-05-22
Start date
2010-06-30
Completion date
2012-03-31
Last updated
2013-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Local Anesthesia, Pain, Postoperative, Self-Perception

Keywords

Local anesthesia, Pain measurement, Pain perception, Dental anesthesia, Root planing

Brief summary

Injectable anesthesics previous to subgingival scaling and root planing (SRP) presents some disadvantages like fear of the needle insertion, long-lasting effect and prolonged dampening of adjacent tissues. This study will compare the intrapocket anesthetic effectiveness of a skin topical anesthesic EMLA with intrapocket 2% benzocaine, intrapocket placebo and injectable anaesthesia for SRP in a Split-mouth, double-blind, clinical trial study.

Detailed description

Objective: The aim of this study was to compare the effect of a eutectic mixture containing 25 mg/g of lidocaine and 25 mg/g of prilocaine (EMLA®) with injectable 2% lidocaine, topical benzocaine, and 2% placebo for reducing pain during subgingival scaling and root planing (SRP) procedures. Methods: Thirty-two patients were enrolled in this split-mouth, double-blind randomized clinical trial. Patients were randomized to a sequence of four anesthetics: 25 mg/g lidocaine and 25 mg/g of 5% prilocaine (EMLA®), injectable 2% lidocaine, topical 2% benzocaine, or placebo. Pain and discomfort were measured using a Visual Analogue Scale (VAS) and Verbal Scale (VS). Patient satisfaction with anesthesia was also determined at the end of each treatment session.

Interventions

DRUGEMLA

% eutectic mixture of 25mg/g lidocaine and 25 mg/g of prilocaine

DRUGInjectable anesthesia

Injectable anesthesia 2% lidocaine with epinephrine 1:100.000

DRUG2% Benzocaine

Topical anesthetic - 200mg/g of 2% benzocaine

DRUGPlacebo

Manipulated with the same appearance and viscosity of topical anesthetics mentioned above

Sponsors

Franciscan University Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* eligible individuals for the study were selected from those requiring SRP with at least 2 experimental teeth in four of the six sextants. * each experimental teeth had to present ≥ 1 site with probing depth ≥ 5 mm associated with BP after treatment of gingivitis (without marginal bleeding). * furthermore, individual should present ≥ 18 years-old, have not ever done periodontal treatment and be able to understand Verbal Scale (VS) and Visual Analog Scale (VAS).

Exclusion criteria

* patients that related allergy history or sensitivity reaction to any used amide or ester anesthetics form, * who received anesthesia or sedation 12 hours before SRP, * who presented ulcerated lesions or abscesses in the oral cavity, * who presented oral pathologies with immediate surgical, * who had prior abuse alcohol history, pregnant women, * who presented uncontrolled hypertension or * who had participated in a clinical trial of investigational drug before four months from the beginning of this study.

Design outcomes

Primary

MeasureTime frameDescription
Pain and discomfortFor each tooth was evaluated intraoperative pain using the Visual Analog Scale (5 minutes after the start of the instrumentation) and postoperative immediately after instrumentation. At the end of the procedure, was asked Verbal Scale, for 4 weeks.For each experimental tooth, the patient was asked to indicate the intensity of pain and discomfort experienced intraoperatively using the VAS (VAStrans) (5 minutes after the start of the instrumentation in each tooth) and postoperatively (VASpost) immediately after the end of instrumentation of the respective tooth. At the end of the procedure, the patient was asked to also describe the pain sensation of the tooth using VS as: no pain (0), mild pain (1), moderate pain (2), severe pain (3), or extremely severe pain (4).

Secondary

MeasureTime frameDescription
Patient satisfaction with anesthesiaDetermined at the end of all treatment sessions, for 4 weeks.Patient satisfaction with anesthesia was determined at the end of all treatment sessions using the following four categories: very satisfactory, satisfied, not satisfied, and completely unsatisfactory.
Injectable anesthetic requirementIf pain persisted after this second application, then an anesthesia infiltration/block was performed, for 4 weeks.Percentage of subjects injectable anesthesia requirements in different anesthetic groups. In case of occurrence of pain during the subgingival SRP, an additional dose of the same anesthesic was repeated. If pain persisted after this second application, then an anesthesia infiltration/block was performed.
Adverse EventsDetermined when each patient returned for the next treatment session, for 4 weeks.When each patient returned for the next treatment session, they were asked about the occurrence of pain, discomfort, localized ulceration, edema, or desquamation of the oral mucosa.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026